The Immunogenicity and Safety of 2013-2014 Seasonal Trivalent Influenza Vaccine
Clinical trial NCT02269852 · COMPLETED
Trial details
- NCT number
- NCT02269852
- Sponsor
- Sinovac Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2014-04-01
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.